The overexpression of APP was the selected method to mimic β-amyloidosis typical of AD brains generating high β-amyloid values; however, it will additionally produce increased levels of APP fragments, such as sAPP, CTF-α, CTF-β, and AICD, which cause some undesirable effects [40,41,42]. This evidence concerns the gene APP and Alzheimer disease.